<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="../../index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="../../index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="../titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="../parts/21CFR862.html">Part 862
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 862.1250  Desoxycorticosterone test system.
                            </h3>
                            <p class="depth0"><em>(a)</em> Identification. A desoxycorticosterone test system is a device  intended to measure desoxycorticosterone (DOC) in plasma and urine. DOC  measurements are used in the diagnosis and treatment of patients with  hypermineralocorticoidism (excess retention of sodium and loss of  potassium) and other disorders of the adrenal gland.</p><p class="depth0"><em>(b)</em> Classification. Class I (general controls). The device is exempt  from the premarket notification procedures in subpart E of part 807 of  this chapter subject to Sec. 862.9.  [52 FR 16122, May 1, 1987, as amended at 65 FR 2306, Jan. 14, 2000]    Sec. 862.1255  2,3-Diphosphoglyceric acid test system.</p><p class="depth0"><em>(a)</em> Identification. A 2,3-diphosphoglyceric acid test system is a  device intended to measure 2,3-diphosphoglyceric acid (2,3-DPG) in  erythrocytes (red blood cells). Measurements of 2,3-diphosphoglyceric  acid are used in the diagnosis and treatment of blood disorders that  affect the delivery of oxygen by erythrocytes to tissues and in  monitoring the quality of stored blood.</p><p class="depth0"><em>(b)</em> Classification. Class I (general controls). The device is exempt  from the premarket notification procedures in subpart E of part 807 of  this chapter subject to the limitations in Sec. 862.9.  [52 FR 16122, May 1, 1987, as amended at 53 FR 21449, June 8, 1988; 66  FR 38787, July 25, 2001]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
